Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement - PubMed (original) (raw)

Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement

M E Medof et al. Proc Natl Acad Sci U S A. 1987 Apr.

Abstract

cDNAs encoding the complement decay-accelerating factor (DAF) were isolated from HeLa and differentiated HL-60 lambda gt cDNA libraries by screening with a codon preference oligonucleotide corresponding to DAF NH2-terminal amino acids 3-14. The composite cDNA sequence showed a 347-amino acid protein preceded by an NH2-terminal leader peptide sequence. The translated sequence beginning at the DAF NH2 terminus encodes four contiguous approximately equal to 61-amino acid long repetitive units of internal homology. The repetitive regions contain four conserved cysteines, one proline, one glycine, one glycine/alanine, four leucines/isoleucines/valines, one serine, three tyrosines/phenylalanines, and one tryptophan and show striking homology to similar regions previously identified in factor B, C2, C4 binding protein, factor H, C1r, factor XIII, interleukin 2 receptor, and serum beta 2-glycoprotein I. The consensus repeats are attached to a 70-amino acid long segment rich in serine and threonine (potential O-glycosylation sites), which is in turn followed by a stretch of hydrophobic amino acids. RNA blot analysis of HeLa and HL-60 RNA revealed three DAF mRNA species of 3.1, 2.7, and 2.0 kilobases. The results indicate that portions of the DAF gene may have evolved from a DNA element common to the above proteins, that DAF cDNA predicts a COOH-terminal anchoring polypeptide, and that distinct species of DAF message are elaborated in cells.

PubMed Disclaimer

Cited by

Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins.
Lublin DM, Liszewski MK, Post TW, Arce MA, Le Beau MM, Rebentisch MB, Lemons LS, Seya T, Atkinson JP. Lublin DM, et al. J Exp Med. 1988 Jul 1;168(1):181-94. doi: 10.1084/jem.168.1.181. J Exp Med. 1988. PMID: 3260937 Free PMC article.
Structure of the axonal surface recognition molecule neurofascin and its relationship to a neural subgroup of the immunoglobulin superfamily.
Volkmer H, Hassel B, Wolff JM, Frank R, Rathjen FG. Volkmer H, et al. J Cell Biol. 1992 Jul;118(1):149-61. doi: 10.1083/jcb.118.1.149. J Cell Biol. 1992. PMID: 1377696 Free PMC article.
Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice.
Liu F, Wu L, Wu G, Wang C, Zhang L, Tomlinson S, Qin X. Liu F, et al. Atherosclerosis. 2014 May;234(1):237-43. doi: 10.1016/j.atherosclerosis.2014.03.004. Epub 2014 Mar 15. Atherosclerosis. 2014. PMID: 24685815 Free PMC article.
Provirus activation plus CD59 blockage triggers antibody-dependent complement-mediated lysis of latently HIV-1-infected cells.
Lan J, Yang K, Byrd D, Hu N, Amet T, Shepherd N, Desai M, Gao J, Gupta S, Sun Y, Yu Q. Lan J, et al. J Immunol. 2014 Oct 1;193(7):3577-89. doi: 10.4049/jimmunol.1303030. Epub 2014 Aug 22. J Immunol. 2014. PMID: 25149467 Free PMC article. Clinical Trial.
Coagulation factor XIII B subunit is encoded by a gene linked to the regulator of complement activation (RCA) gene cluster in man.
Rodriguez de Cordoba S, Rey-Campos J, Dykes DD, McAlpine PJ, Wong P, Rubinstein P. Rodriguez de Cordoba S, et al. Immunogenetics. 1988;28(6):452-4. doi: 10.1007/BF00355378. Immunogenetics. 1988. PMID: 3182017 No abstract available.

References

1. Proc Natl Acad Sci U S A. 1983 Nov;80(22):6947-51 - PubMed
1. Biochemistry. 1986 Nov 4;25(22):6740-7 - PubMed
1. Gene. 1983 Nov;25(2-3):263-9 - PubMed
1. Nature. 1984 Jan 19-25;307(5948):237-41 - PubMed
1. J Exp Med. 1984 Nov 1;160(5):1558-78 - PubMed

Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement - PubMed (original) (raw)